2,163 results on '"Ovarian Neoplasms"'
Search Results
2. The Role of CircDENND4C in Epithelial Ovarian Cancer
3. Biobehavioral and Sociodemographic Characteristics of Long Term Survivors of Ovarian Cancer
4. A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer (RAMP 301)
5. Mesenteric Infiltration in Ovarian Cancer (MIO)
6. Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies
7. Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
8. Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine With or Without Bevacizumab as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II-IV or Recurrent Stage I Epithelial Ovarian or Fallopian Tube Cancer
9. Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, or Breast Cancer
10. Newly Diagnosed Stage III/IV Ovarian Cancer, Neoadjuvant Carbo/Taxol/Pembro, Maintenance Olaparib/Pembro
11. Study BT5528-100 in Patients With Advanced Solid Tumors Associated With EphA2 Expression
12. Paclitaxel Therapeutic Drug Monitoring in Cancer Patients
13. Comparison of Standard of Care Treatment With a Triplet Combination of Targeted Immunotherapeutic Agents
14. Association of Ex Vivo Drug Response (EVDR) and Clinical Outcome in Ovarian Cancer (EXCYTE-1)
15. Niraparib and Neratinib in Advanced Solid Tumors With Expansion Cohort in Advanced Ovarian Cancer (iNNOVATE)
16. Niraparib Rechallenge After Surgery in Ovarian Cancer Patients With Oligometastatic Progression (ANALLISA)
17. Improved Early Diagnosis in Female Pelvic Cancer With OC Detect
18. A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
19. A Study with NKT3447 for Adults with Advanced/Metastatic Solid Tumors
20. A Study of SGN-B6A in Advanced Solid Tumors
21. A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2
22. ACTivating the Immune Response in Ovarian CaNcer (ACTION)
23. Niraparib Maintenance Treatment in Patients with Newly Diagnosed Advanced Platinum- Sensitive, OC. the First Poland RWE Study. (NIRAPARIB)
24. Study of Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis From Colorectal, Appendiceal, Small Bowel, Gastric, Cholangiocarcinoma, Breast, Ovarian, or Other Gynecologic Primary Cancer
25. An Interventional Study of Avastin (Bevacizumab) in Patients With Advanced/Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer
26. Predictors of Relapse of Ovarian, Peritoneal, and Fallopian Tube Cancers
27. Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
28. A Study of NI-1801 in Patients with Mesothelin Expressing Solid Cancers
29. Study of Psilocybin Assisted Psychotherapy to Address Fear of Recurrence
30. Sequential EHR Based Interventions to Increase Genetic Testing for Breast and Ovarian Cancer Predisposition
31. A Study to Characterize the Outcomes of Olaparib Maintenance Monotherapy in Newly Diagnosed BRCAwt Ovarian Cancer (FLAME)
32. Dual mTorc Inhibition in advanCed/Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (of Clear Cell, Endometrioid and High Grade Serous Type, and Carcinosarcoma) (DICE)
33. Removal of the Ovaries/Fallopian Tubes and CA-125 Screening to Reduce the Risk of Ovarian Cancer in Women at Increased Genetic Risk
34. Prehabilitation During the Neoadjuvant Window of Opportunity in Older Women with Ovarian Cancer (FIT4SURGERY)
35. A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors
36. Adebrelimab Combined with Non-platinum Chemotherapy and Fuzuloparib in Recurrent Platinum-resistant Ovarian Cancer
37. The Gynecological Cancer Associated Thrombosis (GynCAT) Study (GynCAT)
38. A Study Evaluating the Efficacy and Safety of Biomarker-Driven Therapies in Patients With Persistent or Recurrent Rare Epithelial Ovarian Tumors (BOUQUET)
39. Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors
40. A Study with NKT3964 for Adults with Advanced/Metastatic Solid Tumors
41. Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Associated With Systemic Chemotherapy in Women With Advanced Ovarian Cancer (PIPACOVA)
42. A Phase I Study of [177Lu]Lu-EVS459 in Patients With Ovarian and Lung Cancers
43. Surgery for Ovarian Cancer After PARPi Therapy in Precision
44. A Study of MOv18 IgE in Folate Receptor Alpha-expressing Platinum Resistant Ovarian Cancer
45. AB-1015, an Integrated Circuit T (ICT) Cell Therapy in Patients with Platinum Resistant Epithelial Ovarian Cancer
46. Nab-Sirolimus and Endocrine Therapy in Recurrent Low Grade Serous Ovarian Cancer (NARETO)
47. Dietary Fiber During Radiotherapy - a Placebo-controlled Randomized Trial (FIDURA)
48. Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) (STARTRK-2)
49. ENB003 Plus Pembrolizumab Phase 1b/2a in Solid Tumors
50. Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies (PETRA)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.